Week 2 '22-23 Mon 10/17-Sun 10/23 | |||||||||
| Team | Coach Rating | M | T | W | T | F | S | S | Total |
|---|---|---|---|---|---|---|---|---|---|
| (8-13) | 23 | 29 | 3 | 40 | -1 | 69 | 3 | 164.2 | |
| (4-17) | 59 | 36 | 13 | 19 | 15 | 23 | -4 | 162.2 | |
| Final Regular Season Game | |||||||||
| Name | Opp | Stats | Day | Total | Pos | Total | Day | Stats | Opp | Name | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
C TOR | 1 Ast | 2.2 | 11.6 | C | 18.8 | 8.2 | 1 G 1 Ast | C FA | ||||
C BOS | — | 1.8 | C | 11 | 9.2 | 2 G | C PIT | |||||
C VGK | — | 14.2 | C | 19.2 | 10.6 | 1 G 2 Ast | C CAR | |||||
LW CAR | 0.4 | 14.8 | LW | 9.8 | 12.8 | 2 G 2 Ast | LW WSH | |||||
RW CHI | 1 G | 3.2 | 7.2 | LW | 30.6 | 11.6 | 1 G 2 Ast | W COL | ||||
LW DAL | 1 Ast | 3.6 | 13.2 | LW | 26.2 | — | LW OTT | |||||
LW VAN | — | 4.4 | RW | 10.8 | — | IRM. Stone RW VGK | ||||||
W SJ | — | 15.8 | RW | 2.4 | 6.4 | 2 Ast | LW LA | |||||
LW FA | — | 17 | RW | 8.2 | — | RW SJ | ||||||
D WSH | 1 G 1 Ast | 8.6 | 17.8 | D | 3 | — | D CGY | |||||
D NSH | 1 Ast | 4.6 | 5.2 | D | 4.6 | — | D CBJ | |||||
D VGK | — | 5.6 | D | -3.6 | -1.2 | D CAR | ||||||
D BUF | — | 22 | D | 17.2 | 1.2 | D BUF | ||||||
G NJ | — | 13.6 | G | 4 | — | G NYI | ||||||
| Total | 22.6 | 164.2 | 162.2 | 58.8 | Total | |||||||
| Optimum | 49 | 183 | 200.2 | 69.6 | Optimum | |||||||
Benched | ||||||||||||
C LA | 1 G 1 Ast | 7.6 | 3.2 | BN | -1 | 0 | C DET | |||||
C FA | 3 Ast | 9.6 | 11.6 | BN | 21.4 | 8.6 | 1 G 1 Ast | C MTL | ||||
LW FA | — | — | BN | 8.2 | — | C BUF | ||||||
C/LW EDM | — | 17.2 | BN | 5.8 | 0.6 | C FLA | ||||||
RW COL | — | 11.4 | BN | 10.4 | — | C/LW STL | ||||||
C/RW ANA | — | 5.4 | BN | 10.6 | — | W BOS | ||||||
W NYR | 1 G | 2.4 | 3.2 | BN | 5.6 | — | IRT. Krug D FA | |||||
D OTT | — | 7.4 | BN | 6.4 | — | D FLA | ||||||
G NYR | 4 GA .879 % | 6.8 | 9.8 | BN | 11 | — | G NYI | |||||
G CBJ | — | 15.6 | BN | 20.6 | 9.2 | 3 GA .923 % | G FA | |||||
| Total | 26.4 | 84.8 | 99 | 18.4 | Total | |||||||
Injured Reserve | ||||||||||||
LW COL | — | — | IR | — | — | C PHI | ||||||